International Stem Cell Corporation (ISCO)
OTCMKTS
· Delayed Price · Currency is USD
0.170
+0.020 (13.33%)
Apr 28, 2026, 4:00 PM EST
International Stem Cell Employees
International Stem Cell had 33 employees as of December 31, 2025. The number of employees increased by 1 or 3.13% compared to the previous year.
Employees
33
Change (1Y)
1
Growth (1Y)
3.13%
Revenue / Employee
$275,758
Profits / Employee
-$12,667
Market Cap
1.39M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Windtree Therapeutics | 14 |
| Evofem Biosciences | 29 |
| Abpro Holdings | 3 |
| LakeShore Biopharma | 573 |
| Iterum Therapeutics | 9 |
| Lyra Therapeutics | 27 |
| CERo Therapeutics Holdings | 8 |
International Stem Cell News
- 1 year ago - International Stem Cell Corporation Announces 2024 Fourth Quarter and Year-End Results - Accesswire
- 2 years ago - Eighteenth edition of Fujio Cup Quiz won by Kasturba Medical College, India in the NCRM NICHE 2023 international stem cell meeting. - Business Wire
- 4 years ago - International Stem Cell Corporation Announces Strong Financial Results for the Quarter Ended March 31, 2022 - Accesswire